HYPERMED PEDIATRIC BRAIN INJURY

Hypoxic Induced Damage including Cerebral Palsy, Autism, Infantile Stroke, Near Drowning, Delayed Development Syndrome, Behavioural and Learning Difficulties, Compulsive Obsessive Disorders, Motor Skill Delay ...

The majority of HyperMED patients are children attending with complex disabilities. Every child is different and case requires specific recommendation - there is never a simple straight forward approach!

HyperMED Protocols are unique - we provide Hyperbaric Oxygenation combined with Lokomat (Gait Training) and other supportive modalities including Median Nerve Stimulation, Whole Body Vibration, immune stimulating supplements etc - please take time to review the following attachments to gain an insight to various disorders, parent observations and testimonials after attending HyperMED.

Hyperbaric Oxygen Treatment of Cerebral Palsy: Review and Comparison to 'Accepted' Therapies (Marois et al)

"A recent study that showed notable improvements in children with CP treated with slightly pressurized air, as well as those treated with a standard protocol for HBOT, is invoked to deny effectiveness of HBOT! Political and economic considerations rather than purely scientific ones play an important role in this controversy. Their is unusual resistance to expanding the indications for this modality ..."

HyperMED UPDATE Chloe Bloch - Near Drowning - Anoxic Enchepalopathy

HyperMED UPDATE Tate Kemp (Ataxic Hypotonic Cerebral Palsy)

HyperMED/Pediatric Inquiry.pdf - General HyperMED inquiry response
HyperMED/HyperMED Pediatric Brain Injury - Cerebral Palsy 2008.pdf - Pediatric Brain Injury Newsletter - Excellent overview!
HyperMED/Cerebral Palsy Functional Outcomes Using HBO, Lokomat, Cerebrolysin Grant Submission.pdf - HyperMED Research Project (2009) submission for funding

Sustainability of motor performance after robotic-assisted treadmill therapy (Lokomat) in children: an open, non-randomized baseline-treatment study.

AIM: The aim of the study was to investigate the sustainability of motor improvements achieved after a three week trial of robotic assisted treadmill therapy in children and adolescents with central gait disorders within a follow up period of about six months. METHODS: Open, non-randomized, baseline-treatment study. Fourteen patients (mean age 8.2+/-5.4) underwent a trial of 12 sessions of robotic-assisted treadmill therapy using the Lokomat over a period of three weeks. Outcome measures were the dimensions D (standing) and E (walking) of the Gross Motor Function Measure, the ten meter walking test and the six minute walking test. Outcome variables were evaluated immediately before and after the trial and at a follow up of about six months. RESULTS: Improvements after the trial in the dimension D from 49.5% to 54.4% (P=0.008) and from 38.9% to 42.3% (P=0.012) in the dimension E of the GMFM were seen and are within the same range of previously published results. The mean score at the follow up after six months was 56.8% and 43.3% for dimension D and E, respectively. Gait speed improved from 0.80 m/s to 1.01 m/s (P=0.006) after the trial and was 1.11 m/s at the follow-up visit at six months. Similar results were obtained for endurance. CONCLUSION: The improvements of motor function after a three-week trial of robotic-assisted treadmill therapy appear to be sustained after a mean period of six months.

Safety of robotic-assisted treadmill therapy in children and adolescents with gait impairment: a bi-centre survey.

OBJECTIVE: The aim of the present study was to report on adverse events encountered with robotic-assisted treadmill therapy in children and adolescents with gait disorders. METHODS: Eighty-nine patients who underwent a trial of robotic assisted treadmill therapy in the two participating centres were analysed. Demographic data and safety data of the patients were analysed using descriptive statistics. RESULTS: In 38 (42.7%) out of 89 patients, adverse events were documented. Most commonly, mild skin erythema at the sites of the cuffs of the device and muscle pain were encountered. In five patients (5.6%), open skin lesions (n = 2), joint pain (n = 2) or tendinopathy (n = 1) limited the continuation of the therapy with the Lokomat. No severe side-effects emerged. CONCLUSIONS: Robotic assisted treadmill therapy is a safe method to enable longer periods of gait therapy in children and adolescents with gait disorders.

Robotic-assisted treadmill therapy improves walking and standing performance in children and adolescents with cerebral palsy.

OBJECTIVE: Task-specific body-weight-supported treadmill therapy improves walking performance in children with central gait impairment. The aim of the study was to investigate the effect of robotic-assisted treadmill therapy on standing and walking performance in children and adolescents with cerebral palsy and to determine parameters influencing outcome. METHODS: 20 Patients (mean age 11.0+/-5.1, 10 males and 10 females) with cerebral palsy underwent 12 sessions of robotic-assisted treadmill therapy using the driven gait orthosis Lokomat. Outcome measures were the dimensions D (standing) and E (walking) of the Gross Motor Function Measure (GMFM). RESULTS: Significant improvements in dimension D by 5.9% (+/-5.2, p=0.001) and dimension E by 5.3% (+/-5.6, p<0.001) of the GMFM were achieved. Improvements in the GMFM D and E were significantly greater in the mildly affected cohort (GMFCS I and II) compared to the more severely affected cohort (GMFCS III and IV). Improvement of the dimension E but not of D correlated positively with the total distance and time walked during the trial (r(s)=0.748, p<0.001). CONCLUSIONS: Children and adolescents with bilateral spastic cerebral palsy showed improvements in the functional tasks of standing and walking after a 3-week trial of robotic-assisted treadmill therapy. The severity of motor impairment affects the amount of the achieved improvement.

What is the purpose of Lokomat - Lokomat used to assist Cerebral Palsy 6 Pediatric Lokomats in the USA

HyperMED Australia : Beyond Therapy - Treatment Program
HyperMED Australia : Lokomat NeuroRecovery
HyperMED/Lokomat - Australian Experience HyperMED NeuroRecovery.pdf
HyperMED/HyperMED Lokomat 2009.pdf
Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study
Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children
A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children (VPH)
Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury
Hyperbaric Oxygenation role in White Matter Hyperintensities - Hyperbaric Oxygen Treatment In Patients With White Matter Hyperintensities On Magnetic Resonance Imaging and Neurologic Deficits
Hyperbaric Treatments for Children With Cerebral Palsy
Atlanta Hyperbaric & Wound Care Clinic, LLC Impact of neural stem cells released by Hyperbaric Oxygenation
http://www.renegadeneurologist.com/category/hyperbaric-oxygen-therapy/
HyperMED Australia : Do Wheel Chairs Inhibit Recovery?

National Geographic Documentary - Professor Ed Cooper - Median Nerve Stimulation

The key message by Prof Cooper is the fact that 'awakening is the result of accurate repetition many thousands of times that tells the brain and spinal cord – wake-up, wake-up, wake- up, wake-up, wake-up ….’ For further reading HyperMED Australia : Median Nerve Stimulation

Median Nerve Stimulation (MNS) is an integral part of the HyperMED Protocol - application is recommend for all patients with neurologic disorders. The Cerebral Palsy and Brain Injured child have vast regions of the brain that remain underdeveloped and immature causing inadequate metabolic and signal responses resulting in 'learned non-use'.

MNS provides a cost effective yet simple home application that enables parents to continue the benefits of HyperMED saturation and training. Equally Spinal Cord patients, victims of neurologic trauma and elderly patients suffering dementia related illness can also benefit from Median Nerve Stimulation. Science supports the fact that many disabled patients have intact but non-responding dormant neural pathways.

These dormant pathways need to 'wake-up!'

Pediatr Phys Ther. 2009 Winter;21(4):308-318

Effects of Intensive Locomotor Treadmill Training on Young Children with Cerebral Palsy.

Mattern-Baxter K, Bellamy S, Mansoor JK. Department of Physical Therapy, University of the Pacific, Stockton, California.

PURPOSE: To examine whether an intensive, short-term locomotor treadmill training program helps children with cerebral palsy (CP) younger than 4 years of age improve their gross motor skills related to ambulation, walking speed, and endurance. METHODS: Six children with cerebral palsy, ages 2.5 to 3.9 years, participated in treadmill training 3 times per week for 1-hour sessions consisting of 2 individualized treadmill walks, for 4 weeks, and were tested before and after the intervention and at a 1-month follow-up. The outcome measures included the Gross Motor Function Measure-66, the Pediatric Evaluation of Disability Inventory, a timed 10-m walk test, and a 6-minute walk test. RESULTS: Significant differences were found in the Gross Motor Function Measure-66 Dimensions D and E, the Pediatric Evaluation of Disability Inventory Mobility Scales, over-ground walking speed, and walking distance. CONCLUSIONS: The results of this study provide preliminary evidence that children with CP younger than 4 years of age can improve their gross motor function, walking speed, and walking endurance after intensive locomotor treadmill training. [PubMed]\

HyperMED UPDATE Adult Cerebral Palsy - Significant Functional Gains